See All Pediatric Endocrinologists in Santa Rosa, CA
Dr. Kaye Fichman, MD

Dr. Kaye Fichman, MD

Age 69 Pediatric Endocrinology F


Dr. Kaye Fichman, MD is a pediatric endocrinology specialist in Santa Rosa, CA. Dr. Fichman completed a residency at Childrens Hospital of Philadelphia. She currently practices at Kaiser Permanente Medical Center. Dr. Fichman is board certified in Pediatric Endocrinology.


  1. Practice

    1. 1
      Kaiser Permanente Medical Center
      3925 Old Redwood Hwy, Santa Rosa, CA 95403 Existing Patients: (707) 566-5303


  • Johns Hopkins, Fellowship Hospital — 1980
  • Childrens Hospital of Philadelphia, Residency Hospital — 1978
  • Childrens Hospital of Philadelphia, Internship Hospital — 1977
  • Johns Hopkins U, School of Medicine, Medical School — 1976

Patient Satisfaction

Be the first to leave a review

How likely are you to recommend Dr. Fichman?

(Select your rating)
See more reviews on Healthgrades
Photo: Dr. Kaye Fichman, MD
Dr. Kaye Fichman, MD
  • Likelihood of recommending Dr. Fichman to family and friends
  • Tell us about your experience with Dr. Fichman

Dr. Fichman's Office & Staff

  • Ease of scheduling urgent appointments
  • Office environment, cleanliness, comfort, etc.
  • Staff friendliness and courteousness
  • Total wait time (waiting & exam rooms)

Experience with Dr. Fichman

  • Level of trust in provider's decisions
  • How well provider explains medical condition(s)
  • How well provider listens and answers questions
  • Spends appropriate amount of time with patients

Tell Us About Yourself

  • Display Name:
  • City, State:
  • Your gender:
  • Your age group:
  • Number of office visits you've had in the last 2 years:

Finish Here

  • How would you like to confirm your survey information?
  • Phone Number:
    Standard text messaging and data rates may apply.
Thank you for sharing your feedback about Dr. Kaye Fichman, MD.
You Might Also Like
People with type 1 diabetes may now be able to worry less about irritating blood sugar checks and unpredictable symptoms. A new “artificial pancreas” has just been approved by the Food and Drug Administration (FDA) and is expected to hit marke...